• Chemicals
• Discovery / R&D
• Generics
• Market Trends
• Pharma Industry Trends
• Pricing & Reimbursement
• Regulatory
• Sales & Marketing
• Therapeutic

M&A in pharma

Explores the merits of mega-deal in contrast to a more measured portfolio growth strategy

In 2008/2009 the pharmaceutical contract research market contracted sharply.   This year growth has returned - the market is up by 13% to $23.5 billion.

But profitability has fallen and mergers and acquisitions continue as the outsourcing industry reacts to changes in the pharmaceutical industry, especially its approach to R&D effectiveness. While bio-pharmaceutical companies will look to complete more and more of their R&D process  in flexible and cost-effective ways the business is becoming more and more about partnership , rather than simple outsourcing. 

It is a complex position, but for a complete picture you need look no further than the Contract Research Annual Review 2010, which provides an in-depth analysis of the CRO market, defining its current position and looking at trends for the future.  And it includes details of mergers, acquisitions and joint ventures. 

With 32 graphs and 19 tables this 240-page review includes:

Introduction
Analysis of CROs by Type of Company
Analysis of the Size of the CRO Market.
CRO Mergers, Acquisitions and Joint Ventures 2009/10
Analysis by Size of CRO
Distribution of CROs by Service Offering
Analysis by Clinical Services Offered
Analysis by Therapeutic Area
CROs in Developing Countries
Analysis of CROs by Size – Numbers of Employees
Summary and Conclusions
CROs in the News (May 2009 – May 2010)

List of Tables & Graphs within Annual Review
Table 1: Distribution of CROs by Company Type as Percentages of Total Numbers
Table 2: Leading Publicly Quoted CROs
Table 3: Estimates of Revenues – Larger Private CROs
Table 4: Publicly Quoted Companies – 2008/09 Income
Table 5: Stock Market Performance of CROs
Table 6: CRO Mergers, Acquisitions & Joint Ventures
Table 7: Absolute Growth Figures for CROs
Table 8: Peak Years of CRO Growth
Table 9: Peak Years of Rates of Formation
Table 10: Number of Beds in CROs by Region
Table 11: Principal Areas of Therapeutic Experience - Europe
Table 12: Principal Areas of Therapeutic Experience - North America
Table 13: CEE CROs
Table 14: South American CROs
Table 15: Asian CROs
Table 16: Staff in CROs in Europe
Table 17: Staff in CROs in North America
Table 18: European Clinical Staff
Table 19: North American Clinical Staff

Figure 1: Types of Company (European) Clinical
Figure 2: Types of Company (European) Preclinical
Figure 3: Types of Company (North American) Clinical
Figure 4: Types of Company (North American) Preclinical
Figure 5: Annual Revenues of Public CROs
Figure 6: Total Annual Revenues of Leading CROs
Figure 7: Market Capitalisation of Leading CROs
Figure 8: Annual Revenues of European CROs
Figure 9: Annual Revenues of North American CROs
Figure 10: Growth of the Overall Market
Figure 11: 3-Year Average Rate of Formation European Clinical CROs
Figure 12: 3-Year Average Rate of Formation European Preclinical CROs
Figure 13: 3-Year Average Rate of Formation North American Clinical CROs
Figure 14: 3-Year Average Rate of Formation North American Preclinical CROs
Figure 15: CRO Services Offered Directly (Europe)
Figure 16: CRO Services Offered Directly (North America)
Figure 17: Clinical CROs by Country
Figure 18: Data Management / Statistics CROs by Country
Figure 19: Regulatory CROs by Country
Figure 20: Preclinical / Toxicology CROs by Country
Figure 21: Analytical CROs by Country
Figure 22: cGMP Labs by Country
Figure 23: Clinical Chemistry (Central Labs) by Country
Figure 24: Evolution of CROs Performing Phase II-IV Studies in Europe
Figure 25: Evolution of CROs Performing Phase II-IV Studies in North America
Figure 26: Evolution of CROs Performing Volunteer Studies in Europe
Figure 27: Evolution of CROs Performing Volunteer Studies in North America
Figure 28: Areas of Therapeutic Experience of European CROs
Figure 29: Other Areas of Experience of European CROs
Figure 30: Areas of Therapeutic Experience of North American CROs
Figure 31: Other Areas of Experience of North American CROs
Figure 32: Number of CROs in CEE